4//SEC Filing
Dutia Suren G 4
Accession 0001213900-20-017080
CIK 0001506251other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:06 PM ET
Size
11.1 KB
Accession
0001213900-20-017080
Insider Transaction Report
Form 4
Dutia Suren G
Director
Transactions
- Award
Options to Purchase Common Stock
2020-07-07+25,000→ 25,000 totalExercise: $1.39Exp: 2030-07-07→ Common Stock (25,000 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (25,000 underlying) - 15,000
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying) - 26,667
Options to Purchase Common Stock
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying)
Footnotes (5)
- [F1]The options vest in full on July 7, 2021.
- [F2]The options vest in full on October 8, 2020.
- [F3]The options vest in full on September 4, 2019.
- [F4]The options vest in full on September 13, 2018.
- [F5]The options granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001514063
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:06 PM ET
- Size
- 11.1 KB